Form 4 for TMO Thermo Fisher Scientific
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001127602-21-028299 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-03 | 2021-11-01+ | TMO | Stevenson Mark | EVP, COO | S - Sale+OE | $635.36 | -53.9K | 59.9K | -47% | -$34.21M |
| DM | 2021-11-03 | 2021-11-01+ | TMO | Stevenson Mark | EVP, COO | M - OptEx | $175.46 | +53.9K | 86.2K | +167% | +$9.45M |
| DM | 2021-11-03 | 2021-11-01+ | TMO | Stevenson Mark | EVP, COO | M - OptEx | $0.00 | -53.9K | 12.4K | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | S | D | 2,367 | $632.70 | 72,334 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.30 to $633.25, inclusive. |
| 2 | Common | Common Stock | 2021-11-02 | S | D | 609 | $642.26 | 59,256 | D | — | — | (F19) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $641.99 to $642.88, inclusive. |
| 3 | Common | Common Stock | 2021-11-01 | M | A | 14,550 | $190.59 | 73,806 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-01 | M | A | 12,375 | $157.68 | 86,181 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-01 | S | D | 1,570 | $628.61 | 84,611 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $628.08 to $629.06, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4. |
| 6 | Common | Common Stock | 2021-11-01 | S | D | 2,000 | $629.71 | 82,611 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $629.21 to $630.16, inclusive. |
| 7 | Common | Common Stock | 2021-11-01 | S | D | 4,141 | $630.69 | 78,470 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.23 to $631.15, inclusive. |
| 8 | Common | Common Stock | 2021-11-01 | S | D | 3,769 | $631.72 | 74,701 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.25 to $632.23, inclusive. |
| 9 | Common | Common Stock | 2021-11-01 | S | D | 6,169 | $633.92 | 66,165 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $633.31 to $634.30, inclusive. |
| 10 | Common | Common Stock | 2021-11-01 | S | D | 5,209 | $634.71 | 60,956 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.31 to $635.29, inclusive. |
| 11 | Common | Common Stock | 2021-11-01 | S | D | 900 | $635.78 | 60,056 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.44 to $636.415, inclusive. |
| 12 | Common | Common Stock | 2021-11-01 | S | D | 800 | $636.82 | 59,256 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.70 to $637.215, inclusive. |
| 13 | Common | Common Stock | 2021-11-02 | M | A | 14,550 | $190.59 | 73,806 | D | — | — | |
| 14 | Common | Common Stock | 2021-11-02 | M | A | 12,375 | $157.68 | 86,181 | D | — | — | |
| 15 | Common | Common Stock | 2021-11-02 | S | D | 500 | $633.27 | 85,681 | D | — | — | (F11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.79 to $633.415, inclusive. |
| 16 | Common | Common Stock | 2021-11-02 | S | D | 1,500 | $635.09 | 84,181 | D | — | — | (F12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.46 to $635.39, inclusive. |
| 17 | Common | Common Stock | 2021-11-02 | S | D | 5,004 | $635.92 | 79,177 | D | — | — | (F13) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.46 to $636.44, inclusive. |
| 18 | Common | Common Stock | 2021-11-02 | S | D | 4,008 | $636.90 | 75,169 | D | — | — | (F14) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.47 to $637.41, inclusive. |
| 19 | Common | Common Stock | 2021-11-02 | S | D | 3,682 | $638.01 | 71,487 | D | — | — | (F15) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $637.51 to $638.50, inclusive. |
| 20 | Common | Common Stock | 2021-11-02 | S | D | 5,741 | $639.06 | 65,746 | D | — | — | (F16) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $638.51 to $639.47, inclusive. |
| 21 | Common | Common Stock | 2021-11-02 | S | D | 3,848 | $640.00 | 61,898 | D | — | — | (F17) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $639.51 to $640.44, inclusive. |
| 22 | Common | Common Stock | 2021-11-02 | S | D | 2,033 | $640.97 | 59,865 | D | — | — | (F18) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $640.65 to $641.34, inclusive. |
| 23 | Derivative | Stock Option (Right to Buy) | 2021-11-01 | M | D | 14,550 | $0.00 | 29,100 | D | $190.59 · 2021-03-07 to 2024-09-07 | 14,550 Common Stock | |
| 24 | Derivative | Stock Option (Right to Buy) | 2021-11-01 | M | D | 12,375 | $0.00 | 24,750 | D | $157.68 · — to 2024-02-28 | 12,375 Common Stock | (F20) The option vested in four equal installments on February 28, 2018, 2019, 2020, and 2021. |
| 25 | Derivative | Stock Option (Right to Buy) | 2021-11-02 | M | D | 14,550 | $0.00 | 14,550 | D | $190.59 · 2021-03-07 to 2024-09-07 | 14,550 Common Stock | |
| 26 | Derivative | Stock Option (Right to Buy) | 2021-11-02 | M | D | 12,375 | $0.00 | 12,375 | D | $157.68 · — to 2024-02-28 | 12,375 Common Stock | (F20) The option vested in four equal installments on February 28, 2018, 2019, 2020, and 2021. |